// App-Quantinova.ai

: Ixekizumab treatment response: Consistency over time and at each visit in psoriatic arthritis

Researchers

Presenter

  • Joseph F. Merola

Principal Investigators

  • Laura C. Coates

  • David M. Soval

  • Rebecca Bolce

  • So Young Park

  • Alyssa Garrelts

  • Keri Brooke Stenger

  • Aubrey Trevelin Sprabery

  • Arthur Kavanaugh

Medical Centers

  • Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA

  • Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom

  • Eli Lilly and Company, Indianapolis, IN

  • University of California, San Diego School of Medicine, La Jolla, CA

Locations

  • United States

  • United Kingdom

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

  • Dermatology

Disease

  • Psoriatic arthritis

  • Psoriasis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

  • LY2439821

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • NCT03151551

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved